2022
DOI: 10.1371/journal.pone.0266405
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsy

Abstract: A comprehensive understanding of the pathological mechanisms involved at different stages of neurodegenerative diseases is key for the advance of preventive and disease-modifying treatments. Gene expression alterations in the diseased brain is a potential source of information about biological processes affected by pathology. In this work, we performed a systematic comparison of gene expression alterations in the brains of human patients diagnosed with Alzheimer’s disease (AD) or Progressive Supranuclear Palsy… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 48 publications
1
0
0
Order By: Relevance
“…Our transcriptional data also reveal critical effects of Aβ-mediated signaling on the regulation of metabolism, electrical activity and synaptic plasticity in hiNs, especially glutamatergic ones. These finding are in accordance with previous studies in AD animal models at the early stages of amyloidopathy [ 38 , 39 , 40 ] and in the brains of patients with AD at the early Braak stages [ 38 , 41 , 42 , 43 , 44 ]. Thus, we believe that our results in hiNs may provide insightful information on the molecular mechanisms mediating Aβ-mediated neuronal hyper-excitability in AD.…”
Section: Discussionsupporting
confidence: 93%
“…Our transcriptional data also reveal critical effects of Aβ-mediated signaling on the regulation of metabolism, electrical activity and synaptic plasticity in hiNs, especially glutamatergic ones. These finding are in accordance with previous studies in AD animal models at the early stages of amyloidopathy [ 38 , 39 , 40 ] and in the brains of patients with AD at the early Braak stages [ 38 , 41 , 42 , 43 , 44 ]. Thus, we believe that our results in hiNs may provide insightful information on the molecular mechanisms mediating Aβ-mediated neuronal hyper-excitability in AD.…”
Section: Discussionsupporting
confidence: 93%